Brenig Therapeutics is a biotechnology company pioneering the development of innovative small-molecule therapies for neurodegenerative diseases
Brenig Therapeutics is a biotechnology company pioneering the development of innovative small-molecule therapies for neurodegenerative diseases. Leveraging decades of drug development expertise and cutting-edge research enhanced by AI and machine learning, we are committed to delivering disease-modifying treatments that target the root causes of debilitating neurological conditions.